LAWRENCE VIDAVER: Open Payments
NPI 1578778585 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$115 in 6 payments from 4 companies in 2025. Trend: 2023 $84 · 2024 $151 · 2025 $115
Food & beverage: $115
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| ABBVIE INC. | 1 | $31 |
| Lundbeck LLC | 1 | $17 |
Products named: REXULTI, Ozempic, VRAYLAR.
Industry payments across MD — which companies pay providers there.
